It has been shown that TREM2 as a lipid and lipoprotein sensor supports reactive microgliosis [24,25,26] and triggers the transcriptional activation of microglial cells by interacting with the apolipoprotein E4 (APOE4), one of the major risk factors for AD [27]. Here, TREM2 is linked to Alzheimer disease.